000 01292 a2200409 4500
005 20250517191719.0
264 0 _c20181109
008 201811s 0 0 eng d
022 _a1476-5373
024 7 _a10.1038/sj.bdj.2017.1039
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPatel, V
245 0 0 _aMRONJ risk of adjuvant bisphosphonates in early stage breast cancer.
_h[electronic resource]
260 _bBritish dental journal
_cJan 2018
300 _a74-79 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aBisphosphonate-Associated Osteonecrosis of the Jaw
650 0 4 _aBone Density Conservation Agents
_xadverse effects
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aDiphosphonates
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aOsteonecrosis
700 1 _aMansi, J
700 1 _aGhosh, S
700 1 _aKwok, J
700 1 _aBurke, M
700 1 _aReilly, D
700 1 _aNizarali, N
700 1 _aSproat, C
700 1 _aChia, K
773 0 _tBritish dental journal
_gvol. 224
_gno. 2
_gp. 74-79
856 4 0 _uhttps://doi.org/10.1038/sj.bdj.2017.1039
_zAvailable from publisher's website
999 _c27890863
_d27890863